Carole Miller, MD, discusses notable factors which correlated with survival for patients with polycythemia vera in the REVEAL study.
Carole Miller
Advertisement
Articles by Carole Miller
Carole Miller, MD, discusses the REVEAL study which enrolled patients with polycythemia vera at both academic and community practices.
Advertisement
Latest Updated Articles
Survival Based on Risk Status in Patients With Polycythemia VeraPublished: March 14th 2022 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
